Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Insulin Dependent Diabetes Mellitus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02637973
What this trial is testing

Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesNon-alcoholic Fatty Liver Disease
The Deutsche Diabetes Forschungsgesellschaft e.V. 84
Post-approval studies (Phase 4)Ended earlyNCT00559286
What this trial is testing

Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels

Who this might be right for
Arterial HypertensionDiabetes Mellitus Type 2 IRC or NIR
RWTH Aachen University 40
Not applicableStudy completedNCT01654341
What this trial is testing

Multi-Modal Intervention In Frail And Prefrail Older People With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Hospital Universitario Getafe 986
Not applicableStudy completedNCT00714441
What this trial is testing

Reducing Distress and Improving Self-Care in Diabetes

Who this might be right for
Diabetes Type 2
University of California, San Francisco 392
Not applicableUnknownNCT05654805
What this trial is testing

Nutraceutical Improvement of Glucose Metabolism, NAFLD and Insulin Resistance by Oat-fiber Supplementation in Type 2 Diabetes Mellitus Patients

Who this might be right for
Type 2 DiabetesNAFLD
Charite University, Berlin, Germany 92
Large-scale testing (Phase 3)Study completedNCT03088670
What this trial is testing

Efficacy and Safety of Gosogliptin as Monotherapy and in Combination With Metformin vs. Vildagliptin as Monotherapy and in Combination With Metformin in Drug-naive Type 2 Diabetic Patients.

Who this might be right for
Diabetes Mellitus, Type 2
SatRx LLC 299
Not applicableStudy completedNCT02009670
What this trial is testing

Inulin,SCFA Production and Metabolic Response

Who this might be right for
Type 2 Diabetes MellitusObesity
Maastricht University Medical Center 15
Not applicableStudy completedNCT03039569
What this trial is testing

Assessing Home Food Environment and Diabetes Self-management Among Adult Type 2 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 2
University of Nebraska Lincoln 79
Testing effectiveness (Phase 2)Study completedNCT03899883
What this trial is testing

Uric Acid Lowering Trial in Youth Onset T2D

Who this might be right for
Diabetic Kidney DiseaseHyperuricemiaDiabetes+5 more
University of Colorado, Denver 11
Not applicableStudy completedNCT04253431
What this trial is testing

The Characteristics of Different Personal Lancets on Blood Volume and Perceived Pain in Patients With Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
HTL-Strefa S.A. 60
Not applicableLooking for participantsNCT06936670
What this trial is testing

Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
Seattle Children's Hospital 90
Post-approval studies (Phase 4)Study completedNCT01611883
What this trial is testing

The Effect of Ezetimibe on Glucose Metabolism in Type 2 Diabetics With Hypercholesterolemia (P06541)

Who this might be right for
Hypercholesterolemia
Organon and Co 152
Post-approval studies (Phase 4)Looking for participantsNCT07719894
What this trial is testing

Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Atherosclerosis
Seoul National University Bundang Hospital 1,200
Not applicableStudy completedNCT05013294
What this trial is testing

Using mHealth (Mobile Health) to Optimize Glycemic Control in Adults With Type 2 Diabetes: Proof of Concept Study

Who this might be right for
Diabetes
KU Leuven 60
Early research (Phase 1)Study completedNCT05925829
What this trial is testing

Stromal Vascular Fraction and Autologous Activated Platelet-Rich Plasma Combination in Treating Treatment of Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Platelet-rich PlasmaStromal Vascular Fraction
Hayandra Peduli Foundation 39
Large-scale testing (Phase 3)UnknownNCT01694173
What this trial is testing

Tissue Distribution of F18-FDG Labelled Autologous Bone Marrow Derived Stem Cells in Patients With Type 2 DM

Who this might be right for
Type 2 Diabetes Mellitus
Post Graduate Institute of Medical Education and Research, Chandigarh 28
Testing effectiveness (Phase 2)Study completedNCT01517373
What this trial is testing

Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 304
Large-scale testing (Phase 3)Study completedNCT04504370
What this trial is testing

Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
PegBio Co., Ltd. 273
Not applicableStudy completedNCT06757751
What this trial is testing

Antidiabetic Potential of Galician High-phenolic Extra Virgin Olive Oils in Patients With Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes Mellitus, Type 2
Fundacin Biomedica Galicia Sur 116
Not applicableStudy completedNCT01089569
What this trial is testing

Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glargine

Who this might be right for
Type 2 Diabetes
HealthPartners Institute 60
Next Page